ACCESSION: MSBNK-SMB_Measured-HSA014P0485000
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 28
COMMENT: RAW_SPEC {'Blanc1-neg_9364': {'bp': 2442050.0, 'sum': 5558198.0}, 'Blanc1-neg_9404': {'bp': 1047399.0, 'sum': 2688777.0}, 'EL17-neg_9139': {'bp': 211757.0, 'sum': 537123.0}, 'EL05-neg_9161': {'bp': 209365.0, 'sum': 504986.0}, 'EL19-neg_9172': {'bp': 205366.0, 'sum': 527043.0}, 'EL06-neg_9154': {'bp': 201083.0, 'sum': 508486.0}, 'EL02-neg_9192': {'bp': 194779.0, 'sum': 502428.0}, 'EL07-neg_9128': {'bp': 192536.0, 'sum': 499018.0}, 'EL21-neg_9129': {'bp': 186856.0, 'sum': 476546.0}, 'EL22-neg_9179': {'bp': 184520.0, 'sum': 460261.0}, 'EL14-neg_9113': {'bp': 180445.0, 'sum': 450437.0}, 'EL16-neg_9113': {'bp': 174615.0, 'sum': 455246.0}, 'EL04-neg_9106': {'bp': 174459.0, 'sum': 439070.0}, 'Blanc3-neg_9070': {'bp': 168607.0, 'sum': 432076.0}, 'EL10-neg_9110': {'bp': 164033.0, 'sum': 424964.0}, 'EL12-neg_9155': {'bp': 162843.0, 'sum': 432518.0}, 'EL09-neg_9125': {'bp': 161356.0, 'sum': 445342.0}, 'EL20-neg_9136': {'bp': 160724.0, 'sum': 426024.0}, 'Blanc2-neg_9069': {'bp': 160343.0, 'sum': 411557.0}, 'EL01-neg_9108': {'bp': 154873.0, 'sum': 416335.0}, 'EL24-neg_9085': {'bp': 145041.0, 'sum': 410077.0}, 'EL08-neg_9119': {'bp': 145023.0, 'sum': 373573.0}, 'EL15-neg_9137': {'bp': 144933.0, 'sum': 373197.0}, 'EL11-neg_9104': {'bp': 143166.0, 'sum': 395819.0}, 'EL23-neg_9115': {'bp': 141208.0, 'sum': 396135.0}, 'EL18-neg_9117': {'bp': 129276.0, 'sum': 341173.0}, 'EL13-neg_9113': {'bp': 128666.0, 'sum': 343999.0}, 'EL03-neg_9105': {'bp': 125734.0, 'sum': 328208.0}}
COMMENT: RETENTION_TIME_STDEV 0.020
COMMENT: PRECURSOR_M/Z_RAW 485.278934
COMMENT: PRECURSOR_M/Z_STDEV 0.000225
COMMENT: PRECURSOR_IN_MS1 mz 485.278866; int 55.343; delta(ppm) 1.022823
COMMENT: PROPOSED_CHARGE_STATE -1; mz 486.282201; int 13.546; cor 0.901
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 4.310; C31H38N2O3; [M-H]1; delta(ppm) -4.310219
COMMENT: PROPOSED_MF SevenGoldenRules 2.832; C22H48O7P2; [M-H]1; delta(ppm) -2.831666
COMMENT: PROPOSED_MF SevenGoldenRules 0.566; C24H43N2O6P; [M-H]1; delta(ppm) 0.565511
COMMENT: PROPOSED_MF SevenGoldenRules 3.963; C26H38N4O5; [M-H]1; delta(ppm) 3.962687
COMMENT: PROPOSED_MF MS-FINDER 3.001; C22H46O9S; [M-H]-; delta(ppm) -0.219736
COMMENT: PROPOSED_MF MS-FINDER 2.990; C26H38N4O5; [M-H]-; delta(ppm) 3.971093
COMMENT: PROPOSED_MF MS-FINDER 2.704; C24H43N2O6P; [M-H]-; delta(ppm) 0.567331
COMMENT: PROPOSED_MF MS-FINDER 2.696; C31H38N2O3; [M-H]-; delta(ppm) -4.318449
COMMENT: PROPOSED_MF MS-FINDER 2.682; C17H43N8O4PS; [M-H]-; delta(ppm) -0.845878
COMMENT: PROPOSED_MF MS-FINDER 2.606; C25H39N6O2P; [M-H]-; delta(ppm) -2.188635
COMMENT: PROPOSED_MF MS-FINDER 2.591; C18H44N6O5P2; [M-H]-; delta(ppm) 2.697166
COMMENT: PROPOSED_MF MS-FINDER 2.588; C17H51N4O3PS3; [M-H]-; delta(ppm) 0.119332
COMMENT: PROPOSED_MF MS-FINDER 2.523; C10H35N18O3P; [M-H]-; delta(ppm) -3.224288
COMMENT: PROPOSED_MF MS-FINDER 2.523; C12H30N20O2; [M-H]-; delta(ppm) 0.179449
COMMENT: PROPOSED_MF MS-FINDER 2.439; C27H34N8O; [M-H]-; delta(ppm) 1.215109
COMMENT: PROPOSED_MF MS-FINDER 2.429; C12H38N16OS2; [M-H]-; delta(ppm) 1.144661
COMMENT: PROPOSED_MF MS-FINDER 2.413; C18H52N2O4P2S2; [M-H]-; delta(ppm) 3.662382
COMMENT: PROPOSED_MF MS-FINDER 2.393; C15H38N10O8; [M-H]-; delta(ppm) -2.598149
COMMENT: PROPOSED_MF MS-FINDER 2.388; C15H48N6O5P2S; [M-H]-; delta(ppm) -4.249608
COMMENT: PROPOSED_MF MS-FINDER 2.388; C15H46N6O7S2; [M-H]-; delta(ppm) -1.632943
COMMENT: PROPOSED_MF MS-FINDER 2.372; C22H48O7P2; [M-H]-; delta(ppm) -2.836409
COMMENT: PROPOSED_MF MS-FINDER 2.368; C19H38N10O3S; [M-H]-; delta(ppm) 2.557875
COMMENT: PROPOSED_MF MS-FINDER 2.357; C26H46O4S2; [M-H]-; delta(ppm) 4.936313
COMMENT: PROPOSED_MF MS-FINDER 2.353; C11H34N16O6; [M-H]-; delta(ppm) 2.935428
COMMENT: PROPOSED_MF MS-FINDER 2.344; C13H39N14O2PS; [M-H]-; delta(ppm) 4.687719
COMMENT: PROPOSED_MF MS-FINDER 2.310; C23H42N4O5S; [M-H]-; delta(ppm) -2.975698
COMMENT: PROPOSED_MF MS-FINDER 2.278; C23H50O4S3; [M-H]-; delta(ppm) -2.010492
COMMENT: PROPOSED_MF MS-FINDER 2.234; C17H59O2PS5; [M-H]-; delta(ppm) 1.084544
COMMENT: PROPOSED_MF MS-FINDER 2.178; C11H42N12O5S2; [M-H]-; delta(ppm) 3.900645
COMMENT: PROPOSED_MF MS-FINDER 2.159; C19H46N6O2S3; [M-H]-; delta(ppm) 3.523092
COMMENT: PROPOSED_MF MS-FINDER 2.130; C16H42N10O3S2; [M-H]-; delta(ppm) -4.388896
COMMENT: PROPOSED_MF MS-FINDER 2.114; C16H50N6O2S4; [M-H]-; delta(ppm) -3.423693
COMMENT: PROPOSED_MF MS-FINDER 2.086; C16H58N2OS6; [M-H]-; delta(ppm) -2.458488
COMMENT: PROPOSED_MF MS-FINDER 2.061; C27H42N4S2; [M-H]-; delta(ppm) 2.180323
COMMENT: PROPOSED_MF MS-FINDER 2.025; C12H46N12S4; [M-H]-; delta(ppm) 2.109875
COMMENT: PROPOSED_MF MS-FINDER 1.916; C19H54N2OS5; [M-H]-; delta(ppm) 4.488311
COMMENT: PROPOSED_MF MS-FINDER 1.755; C24H46N4S3; [M-H]-; delta(ppm) -4.766443
COMMENT: PROPOSED_MF SIRIUS5_Sirius 3.706; C22H46O9S; [M-H]-; delta(ppm) -0.219736
COMMENT: PROPOSED_MF SIRIUS5_Sirius 2.812; C26H46O4S2; [M-H]-; delta(ppm) 4.936313
COMMENT: PROPOSED_MF SIRIUS5_Sirius 2.810; C25H42O9; [M-H]-; delta(ppm) 6.727093
COMMENT: PROPOSED_MF SIRIUS5_Sirius 0.632; C26H38N4O5; [M-H]-; delta(ppm) 3.971093
COMMENT: PROPOSED_MF SIRIUS5_Sirius 0.592; C31H38N2O3; [M-H]-; delta(ppm) -4.318449
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.432; C29H43O4P; [M-H]-; delta(ppm) -7.722155
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.482; C30H43ClO3; [M-H]-; delta(ppm) -47132.803143
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.712; C22H46O9S; [M-H]-; delta(ppm) -0.219736
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.288; C26H46O4S2; [M-H]-; delta(ppm) 4.936313
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.091; C22H46O9S; [M-H]-; delta(ppm) -0.219736
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.971; C23H42N4O5S; [M-H]-; delta(ppm) -2.975698
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.197; C26H46O4S2; [M-H]-; delta(ppm) 4.936313
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.147; C21H46N4O3Si3; [M-H]-; delta(ppm) -116429.171537
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.229; C25H43ClN2O5; [M-H]-; delta(ppm) -47125.276542
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.817; C23H47FO5S2; [M-H]-; delta(ppm) 2.581662
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.441; C20H43FN4O6S; [M-H]-; delta(ppm) -5.330312
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.810; C25H42O9; [M-H]-; delta(ppm) 6.727093
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.262; C24H43N2O6P; [M-H]-; delta(ppm) 0.567331
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.632; C26H38N4O5; [M-H]-; delta(ppm) 3.971093
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.419; C22H46O9S; [M-H]-; delta(ppm) -0.219736
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.404; C23H42N4O5S; [M-H]-; delta(ppm) -2.975698
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.175; C26H46O4S2; [M-H]-; delta(ppm) 4.936313
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C21H46N4O3Si3; [M-H]-; delta(ppm) -116429.171537
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C25H42O9; [M-H]-; delta(ppm) 6.727093
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.463; CILQGDJCXHLODI-UHFFFAOYNA-N; [M-H]-; CCN(CC)C1=CC2OC3=C(C=C(C)C(=C3)N(CC)CC)C(=C2C=C1C)C1=CC=CC=C1C(=O)OC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.453; PGQXGWUGIBIDNM-UHFFFAOYSA-N; [M-H]-; O=S(=O)(O)OCCOCCOCCOCCOCCOCCCCCCCCCCCC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.410; PHVYTGYUWMNRDR-UHFFFAOYSA-N; [M-H]-; O=C([O-])C1=C2CC3CCC4CCCCC(=O)C1(O)CC24C53C[N+](=CCC5CNCCO)C(=N)NC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.408; KMDGCQCDKFMKAD-WORHRAFRSA-N; [M-H]-; C[C@H]1CC[C@]2(C)[C@@H](CCC=C2C)[C@]1(C)CC1=C(O)C(=O)C=C(NCCC2=CNC3=CC=CC=C23)C1=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.358; PEEHTCHYBKJTRF-UHFFFAOYSA-N; [M-H]-; O=C(O)C1=C2CC3CCC4CCCCC(=O)C1(O)CC24C53CN(C=CC5CNCCO)C(=N)NC
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.970; PGQXGWUGIBIDNM-UHFFFAOYSA-N; [M-H]-; 1,4,7,10,13,16-hexaoxaoctacosane-1-sulfonic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.829; KQIOUTNGDCAUPX-UHFFFAOYSA-N; [M-H]-; 2-({[(3-methyl-4-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}-6-(propan-2-yl)cyclohex-2-en-1-yl)methyl]carbamoyl}methoxy)acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.821; LOALBDSDXWHRAT-SQTUVHKDNA-N; [M-H]-; 1-[[(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.798; CQHYKILOLYQRAA-UHFFFAOYSA-N; [M-H]-; bis(2-methoxyethyl)[(3-methyl-4-{[5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl]methyl}-6-(propan-2-yl)cyclohex-2-en-1-yl)methyl]amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.763; FSNBZSSODNZVPY-UHFFFAOYSA-N; [M-H]-; CNP0431731
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.753; BYHRHPCOMGGPRI-UHFFFAOYSA-N; [M-H]-; 11-hydroxy-7-{[(2-hydroxyethyl)amino]methyl}-11-(methoxymethyl)-18-methyl-4-(N-methylcarbamimidoyl)-4-azapentacyclo[8.8.0.0?,??.0?,?.0?,??]octadeca-5,8,12-triene-12-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.740; DICXGCKLBDKHNC-UHFFFAOYSA-N; [M-H]-; 2-(6,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-3-yl)-N-(3-methoxypropyl)-N-[(octahydro-1H-quinolizin-1-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.740; PHVYTGYUWMNRDR-UHFFFAOYSA-N; [M-H]-; CNP0441371
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.740; PEEHTCHYBKJTRF-UHFFFAOYSA-N; [M-H]-; 12'-hydroxy-4-{[(2-hydroxyethyl)amino]methyl}-1-(N-methylcarbamimidoyl)-11'-oxo-2,4-dihydro-1H-spiro[pyridine-3,2'-tetracyclo[10.2.1.1?,??.0?,?]hexadecan]-13'-ene-13'-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.740; YAPWBDNGFGGLBV-UHFFFAOYSA-N; [M-H]-; 2-(7,8-dimethoxy-1-oxo-1,2-dihydrophthalazin-2-yl)-N-(3-methoxypropyl)-N-[(octahydro-1H-quinolizin-1-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.709; HBEUUKOTKBTDDO-UHFFFAOYSA-N; [M-H]-; methyl 2-({1-acetyl-4-[4-(dimethylamino)benzoyl]piperazin-2-yl}formamido)-3-cyclohexylpropanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.709; NHUJKQQHPXUHSP-UHFFFAOYSA-N; [M-H]-; methyl 1-(3-{6-[(4-methoxyphenyl)methyl]-1-methyl-5-oxo-decahydropyrrolo[3,2-e][1,4]diazepin-2-yl}propanoyl)piperidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.706; KCPPXCABDVTJRM-UHFFFAOYSA-N; [M-H]-; N-(2-methoxyethyl)-3-[1-(4-methoxyphenyl)-2,5-dioxoimidazolidin-4-yl]-N-[(octahydro-1H-quinolizin-1-yl)methyl]propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.701; NRHOTUHOJWMFFP-UHFFFAOYSA-N; [M-H]-; 2-(6,7-dimethoxy-2-methyl-4-oxo-3,4-dihydroquinazolin-3-yl)-N-(2-methoxyethyl)-N-[(octahydro-1H-quinolizin-1-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.694; FKESLNCFQIAMJE-UHFFFAOYSA-N; [M-H]-; 3-{1-[(3,4-dimethoxyphenyl)methyl]-2,5-dioxoimidazolidin-4-yl}-N-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.694; OINKQIHBCTVJNI-UHFFFAOYSA-N; [M-H]-; N-(2-methoxyethyl)-2-{1-[(4-methoxyphenyl)methyl]-2,5-dioxoimidazolidin-4-yl}-N-[(octahydro-1H-quinolizin-1-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.691; SZJRKITVRBMKNW-UHFFFAOYSA-N; [M-H]-; 3-{1-[2-(3,4-dimethoxyphenyl)ethyl]-2,5-dioxoimidazolidin-4-yl}-N-[(octahydro-1H-quinolizin-1-yl)methyl]propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.688; AYJDQBJSTNNDJM-UHFFFAOYSA-N; [M-H]-; 2-{1-[2-(3,4-dimethoxyphenyl)ethyl]-2,5-dioxoimidazolidin-4-yl}-N-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.455; KMDGCQCDKFMKAD-WORHRAFRSA-N; [M-H]-; UNPD223960
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.433; CILQGDJCXHLODI-UHFFFAOYNA-N; [M-H]-; Xanthylium, 3,6-bis(ethylamino)-9-[2-(methoxycarbonyl)phenyl]-2,7-dimethyl-, molybdatetungstatephosphate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; PHVYTGYUWMNRDR-UHFFFAOYSA-N; [M-H]-; CNP0441371
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; CILQGDJCXHLODI-UHFFFAOYNA-N; [M-H]-; Xanthylium, 3,6-bis(ethylamino)-9-[2-(methoxycarbonyl)phenyl]-2,7-dimethyl-, molybdatetungstatephosphate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; KMDGCQCDKFMKAD-WORHRAFRSA-N; [M-H]-; UNPD223960
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; LOALBDSDXWHRAT-SQTUVHKDNA-N; [M-H]-; 1-[[(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; AYJDQBJSTNNDJM-UHFFFAOYSA-N; [M-H]-; 2-{1-[2-(3,4-dimethoxyphenyl)ethyl]-2,5-dioxoimidazolidin-4-yl}-N-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; BYHRHPCOMGGPRI-UHFFFAOYSA-N; [M-H]-; 11-hydroxy-7-{[(2-hydroxyethyl)amino]methyl}-11-(methoxymethyl)-18-methyl-4-(N-methylcarbamimidoyl)-4-azapentacyclo[8.8.0.0?,??.0?,?.0?,??]octadeca-5,8,12-triene-12-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; CQHYKILOLYQRAA-UHFFFAOYSA-N; [M-H]-; bis(2-methoxyethyl)[(3-methyl-4-{[5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl]methyl}-6-(propan-2-yl)cyclohex-2-en-1-yl)methyl]amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; DICXGCKLBDKHNC-UHFFFAOYSA-N; [M-H]-; 2-(6,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-3-yl)-N-(3-methoxypropyl)-N-[(octahydro-1H-quinolizin-1-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FKESLNCFQIAMJE-UHFFFAOYSA-N; [M-H]-; 3-{1-[(3,4-dimethoxyphenyl)methyl]-2,5-dioxoimidazolidin-4-yl}-N-methyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FSNBZSSODNZVPY-UHFFFAOYSA-N; [M-H]-; CNP0431731
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; HBEUUKOTKBTDDO-UHFFFAOYSA-N; [M-H]-; methyl 2-({1-acetyl-4-[4-(dimethylamino)benzoyl]piperazin-2-yl}formamido)-3-cyclohexylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; KCPPXCABDVTJRM-UHFFFAOYSA-N; [M-H]-; N-(2-methoxyethyl)-3-[1-(4-methoxyphenyl)-2,5-dioxoimidazolidin-4-yl]-N-[(octahydro-1H-quinolizin-1-yl)methyl]propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; KQIOUTNGDCAUPX-UHFFFAOYSA-N; [M-H]-; 2-({[(3-methyl-4-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}-6-(propan-2-yl)cyclohex-2-en-1-yl)methyl]carbamoyl}methoxy)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NHUJKQQHPXUHSP-UHFFFAOYSA-N; [M-H]-; methyl 1-(3-{6-[(4-methoxyphenyl)methyl]-1-methyl-5-oxo-decahydropyrrolo[3,2-e][1,4]diazepin-2-yl}propanoyl)piperidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NRHOTUHOJWMFFP-UHFFFAOYSA-N; [M-H]-; 2-(6,7-dimethoxy-2-methyl-4-oxo-3,4-dihydroquinazolin-3-yl)-N-(2-methoxyethyl)-N-[(octahydro-1H-quinolizin-1-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; OINKQIHBCTVJNI-UHFFFAOYSA-N; [M-H]-; N-(2-methoxyethyl)-2-{1-[(4-methoxyphenyl)methyl]-2,5-dioxoimidazolidin-4-yl}-N-[(octahydro-1H-quinolizin-1-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; PEEHTCHYBKJTRF-UHFFFAOYSA-N; [M-H]-; 12'-hydroxy-4-{[(2-hydroxyethyl)amino]methyl}-1-(N-methylcarbamimidoyl)-11'-oxo-2,4-dihydro-1H-spiro[pyridine-3,2'-tetracyclo[10.2.1.1?,??.0?,?]hexadecan]-13'-ene-13'-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SZJRKITVRBMKNW-UHFFFAOYSA-N; [M-H]-; 3-{1-[2-(3,4-dimethoxyphenyl)ethyl]-2,5-dioxoimidazolidin-4-yl}-N-[(octahydro-1H-quinolizin-1-yl)methyl]propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; YAPWBDNGFGGLBV-UHFFFAOYSA-N; [M-H]-; 2-(7,8-dimethoxy-1-oxo-1,2-dihydrophthalazin-2-yl)-N-(3-methoxypropyl)-N-[(octahydro-1H-quinolizin-1-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; CILQGDJCXHLODI-NDEPHWFRSA-N; [M-H]-; methyl 2-[(4aS)-3,6-bis(diethylamino)-2,7-dimethyl-4aH-xanthen-9-yl]benzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; MVXRTLWIKNHZBT-UHFFFAOYSA-N; [M-H]-; 2-[3-[[(2-benzhydryl-1-azabicyclo[2.2.2]octan-3-yl)amino]methyl]-4-methoxyphenyl]propane-1,2-diol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -102.591; PGQXGWUGIBIDNM; [M-H]-; 3,6,9,12,15-Pentaoxaheptacosan-1-ol, hydrogen sulfate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -381.174; DTLNHSKTUGGNSN; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.126; PGQXGWUGIBIDNM; [M-H]-; 3,6,9,12,15-Pentaoxaheptacosan-1-ol, hydrogen sulfate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -197.758; PGQXGWUGIBIDNM; [M-H]-; 1,4,7,10,13,16-hexaoxaoctacosane-1-sulfonic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -291.779; DTLNHSKTUGGNSN; [M-H]-; 1-{[3-(acetyloxy)undec-5-en-1-yl]disulfanyl}undec-5-en-3-yl acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.254; PGQXGWUGIBIDNM; [M-H]-; 1,4,7,10,13,16-hexaoxaoctacosane-1-sulfonic acid
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C22H45O9S1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 15.654
MS$FOCUSED_ION: PRECURSOR_M/Z 485.278871
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000j-9000700000-4cd22c9da68da8acc22c
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  79.9559253 161.7290 79.955914 0.7004 11.60 0.8511 28 ?
  80.9637134 15.8451 80.963703 1.3957 4.00 0.3487 24 ?
  95.9508375 35.0193 95.950845 1.2298 7.45 0.6256 28 ?
  96.9586884 999.0000 96.958697 0.4744 1.18 0.9163 28 ?
  98.9544696 25.4634 98.954481 1.2026 3.63 0.5765 24 ?
  122.9744648 54.9424 122.974518 1.2360 7.56 0.6447 27 ?
  485.2789341 883.6710 485.279499 0.5131 71.48 1.0000 28 f{C22H45O9S1}/-0.09ppm,p
  486.2820956 210.5301 486.282661 0.6437 21.32 0.8856 28 ?
PK$NUM_PEAK: 8
PK$PEAK: m/z int. rel.int.
  79.955925 161.73 161
  80.963713 15.85 15
  95.950838 35.02 35
  96.958688 999.00 999
  98.954470 25.46 25
  122.974465 54.94 54
  485.278934 883.67 883
  486.282096 210.53 210
//
